# Glioblastoma: Validation and Comparison Between Primary Tumor and Its Murine Model

> **NCT02904525** · NA · UNKNOWN · sponsor: **Andreas Hottinger** · enrollment: 20 (estimated)

## Conditions studied

- Glioblastoma

## Interventions

- **DEVICE:** 7 Tesla MRI, no contrast agent

## Key facts

- **NCT ID:** NCT02904525
- **Lead sponsor:** Andreas Hottinger
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-06
- **Primary completion:** 2021-01-27
- **Final completion:** 2021-04-30
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2021-01-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02904525

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02904525, "Glioblastoma: Validation and Comparison Between Primary Tumor and Its Murine Model". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02904525. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*